NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology

Area of Science:

• Nephrology
• Cardiovascular Biology
• Oxidative Stress Research

Background:

• Acute ischemic renal injury involves complex pathophysiological mechanisms.
• Imbalance in nitric oxide synthase isoforms (iNOS and eNOS) and increased oxidant stress contribute to renal damage.
• Endothelial cell dysfunction is an early event in acute renal ischemia.

Purpose of the Study:

• To review the current evidence on the role of iNOS/eNOS imbalance, oxidant stress, and peroxynitrite in acute ischemic renal injury.
• To focus on the development of endothelial cell dysfunction in early stages of experimental acute renal ischemia.
• To explore future perspectives on endothelial progenitor cells for preventing and treating acute renal failure.

Main Methods:

• Literature review of current evidence on nitric oxide synthase imbalance and oxidant stress in renal ischemia.
• Analysis of studies investigating endothelial cell dysfunction in experimental acute renal ischemia.
• Examination of research on the therapeutic potential of infused endothelial cells and endothelial progenitor cells.

Main Results:

• Evidence suggests a critical role for iNOS/eNOS imbalance and peroxynitrite generation in acute ischemic renal injury.
• Endothelial cell dysfunction is a key early feature of experimental renal ischemia.
• Studies show amelioration of renal injury through endothelial cell engraftment in the renal microcirculation.

Conclusions:

• The pathophysiology of acute ischemic renal injury is linked to iNOS/eNOS imbalance and oxidant stress.
• Endothelial cell dysfunction plays a significant role in the early stages of renal ischemia.
• Endothelial progenitor cells represent a promising future strategy for managing acute renal failure.